Principles to Inform Drug Pricing, Access and Innovation Policy

November 12, 2024

Impacts of Expanding and Lowering a Cap on Out-of-Pocket Drug Costs

November 1, 2024

Fact Sheet: Expanding Access to Mpox Vaccines Through Affordable Transparent Pricing

October 30, 2024

FOIA Findings Reveal Pharma Influence on Trump Administration 2017-2018 Plans to Address U.S. Drug Prices

Key Facts to Know Before Novo Nordisk’s CEO Appears at the Senate HELP Committee

September 17, 2024

Estimate of Savings from Generic Competitors to Ozempic and Wegovy

Mpox Response: Public Citizen Research & Advocacy

Expanding Access to Semaglutide through 28 U.S.C. § 1498

August 5, 2024

Eli Lilly State Lobbying Disclosure Chart